Tiffany G. Harris
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tiffany G. Harris has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Howard D. Strickler
Albert Einstein College of Medicine, Bronx, NY, USA
2 shared publicationsXiaonan Xue
Albert Einstein College of Medicine, Bronx, NY, USA
2 shared publicationsAlexandra M. Levine
1 shared publication- Charles B. Hall
Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, USA
1 shared publication D. Heather Watts
1 shared publicationE. Scott Monrad
Albert Einstein College of Medicine, Bronx, NY, USA
1 shared publication
Latest Publications
- 1 April 2006
- Published by Elsevier in Growth Hormone & IGF Research
- Vol. 16 (2) , 86-92
Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3)
- 1 April 2006
- Published by Elsevier in Growth Hormone & IGF Research
- Vol. 16 (2) , 86-92
Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3)
- Open Access
- 23 March 2005
- Published by American Medical Association (AMA) in JAMA
- Vol. 293 (12) , 1471-1476
Incidence of Cervical Squamous Intraepithelial Lesions Associated With HIV Serostatus, CD4 Cell Counts, and Human Papillomavirus Test Results
Cervical cancer screening recommendations in the United States have been recently updated and now advise using an interval of 3 years between screenings in healthy women 30 years or older who have normal cytology results and who test negative for oncogenic (cancer-associated) human papillomavirus (HPV) DNA.1,2 The recommended interval is 6 to 12 months for women with normal cytology results and detectable oncogenic HPV. If no HPV test is conducted, 3 consecutive normal annual Papanicolaou (Pap) smear results are required before the Pap smear frequency is changed to once every 2 or 3 years. Support for these recommendations comes from several large observational studies.1-5
- 23 March 2005
- Published by American Medical Association (AMA) in JAMA
- Vol. 293 (12) , 1471-1476
Open AccessIncidence of Cervical Squamous Intraepithelial Lesions Associated With HIV Serostatus, CD4 Cell Counts, and Human Papillomavirus Test Results
Cervical cancer screening recommendations in the United States have been recently updated and now advise using an interval of 3 years between screenings in healthy women 30 years or older who have normal cytology results and who test negative for oncogenic (cancer-associated) human papillomavirus (HPV) DNA.1,2 The recommended interval is 6 to 12 months for women with normal cytology results and detectable oncogenic HPV. If no HPV test is conducted, 3 consecutive normal annual Papanicolaou (Pap) smear results are required before the Pap smear frequency is changed to once every 2 or 3 years. Support for these recommendations comes from several large observational studies.1-5